Quick answer. Olin and Huntsman's $12.5 billion all-stock merger — shareholder-approved on August 25, 2026, and on track to close in H1 2027 — does not remove a competing MDI producer from the market; Huntsman keeps its Geismar, Rotterdam, and Caojing plants under a new parent. What changes is feedstock: Huntsman finally gets in-house chlorine and phosgene from Olin, closing an integration gap BASF, Dow, and Covestro closed decades ago. For polyurethane system buyers, the near-term risk is integration-period allocation and service disruption, not a sudden drop in supplier count.
The timing is why this is worth reading now rather than after the fact. Olin investors approved the deal with roughly 97% of votes cast, Huntsman investors with roughly 99%, at special meetings held two days before this article was written. Antitrust clearance is the last major gate before a combined OlinHuntsman controls chlorine, MDI, and epoxy feedstock inside one boardroom.
An all-stock, near-even split like this one also tells you something about pace. Neither side is raising cash by selling a plant, so there's no forced fire-sale of MDI capacity to fund the deal — the pressure on buyers is procedural integration friction, not a sudden capacity cut.
What Actually Changed in the Deal
Olin and Huntsman signed a definitive merger-of-equals agreement structured as an all-stock exchange: every Huntsman share converts into 0.5476 shares of the combined company. Olin holders end up with roughly 54.5% of the new entity, Huntsman holders roughly 45.5%.
The combined firm will operate as OlinHuntsman Corporation once the deal closes, with about $12.5 billion in combined 2025 revenue and more than $400 million in identified cost synergies. Management is targeting a close in the first half of 2027, subject to antitrust clearance.
No plant changes hands to a rival producer. Huntsman's MDI and polyurethane-systems business — its Geismar, Louisiana plant, its Rotterdam, Netherlands unit, and its Caojing, China joint-venture line, split from BASF's share of that venture in 2023 — stays inside the same production organization, now funded off Olin's balance sheet.
Why This Is Vertical Integration, Not Fewer MDI Suppliers
Read the deal as a chlorine story first. Olin is one of North America's largest chlor-alkali producers; its chlorine feeds phosgene, and phosgene is the starting point for MDI and TDI production. Huntsman has been the only major global MDI producer without its own chlor-alkali base — BASF, Dow, and Covestro all make their own chlorine.
That gap showed up in Huntsman's cost curve every time chlorine spiked. Folding Olin's upstream chlorine and phosgene capacity into the same company removes that structural disadvantage and lets the combined firm capture margin at two links of the chain instead of one.
The same chlorine stream also feeds epichlorohydrin for Olin's epoxy-resin business, so OlinHuntsman becomes integrated from chlorine through both MDI-based polyurethanes and epoxy — a footprint neither company's direct competitors currently match end to end.
BASF, Dow, and Covestro built that chlorine-to-MDI link decades ago precisely because chlor-alkali and MDI margins move on different cycles. When chlorine tightens, an integrated producer keeps supplying merchant MDI at a stable margin while a non-integrated producer has to pass the spike straight through or absorb it. Huntsman spent decades absorbing that spike as a non-integrated producer; OlinHuntsman won't have to.
Where the Real Risk Sits for Buyers
The count of major global MDI producers doesn't drop. BASF, Covestro, Dow, Wanhua, Kumho Mitsui, and OlinHuntsman are still separate companies bidding for your volume. The risk shifts into three narrower windows instead of one broad "fewer suppliers" story.
| Risk window | What's actually happening | Buyer exposure | Time horizon |
|---|---|---|---|
| Integration period | Plant, ERP, and sales-desk systems merge across two formerly separate companies | Order-confirmation delays, temporary allocation, account-rep turnover | H2 2026 – late 2028 |
| Feedstock repricing | Huntsman's MDI cost base improves as captive chlorine/phosgene displaces merchant purchases | Not a direct line-item cost, but resets OlinHuntsman's floor price and downturn discounting behavior | 2027 onward |
| Portfolio rationalization | Combined boards typically prune overlapping or subscale assets within 24 months of close | Possible idling or reallocated volume among Geismar, Rotterdam, and Caojing | 2027 – 2029 |
| Antitrust conditions | Regulators may require divestitures in overlapping chemistries as a condition of clearance | Unknown until clearance; watch for required MDI or intermediate divestitures | Now – H1 2027 |
The first two rows deserve a contract clause today. The last two deserve a calendar reminder — worth tracking as antitrust filings and integration announcements land, but not worth renegotiating a supply agreement over before there's a specific plant or divestiture named.
A 12-18 Month Procurement Playbook
Buyers don't need to panic-source. The next 12 to 18 months reward whoever moves before the close, not after it.
- Lock volume on current Huntsman contracts through at least Q4 2027, while renewal terms still reference pre-merger account structures.
- Split MDI exposure across at least two producer groups — Huntsman/OlinHuntsman plus one of BASF, Covestro, Dow, or Wanhua — so one integration hiccup doesn't stop a production line.
- Get your nominated supply plant — Geismar, Rotterdam, or Caojing — named in writing, with a backup plant named in the same document.
- Carry 3-4 weeks of buffer inventory on critical MDI grades through the 2027 systems-integration window, matching what most buyers held through the 2020-2022 force-majeure cycle.
- Add an M&A-specific clause to your force majeure and allocation language now, before renewal, so a merger-driven plant transfer or ERP cutover is explicitly covered rather than argued over later.
None of this requires new capex. It requires renegotiating paper before the counterparty on the other end of it changes.
Why Buyers Are Rechecking Their Polyol-System Relationships Now
MDI is one half of every polyurethane system; the polyol blend, catalyst package, surfactant, and flame-retardant package is the other half. A merger on the isocyanate side is a reasonable trigger to re-audit who formulates that other half.
A manufacturer-direct polyol-systems formulator isn't captive to one MDI producer's allocation decisions or plant schedule. We run blendpolyol's polyurethane elastomer systems on MDI sourced from whichever producer a customer already holds under contract, so an MDI-side disruption doesn't force a system reformulation on top of a sourcing scramble.
That separation also keeps density, ILD, flame-retardant loading, and pot-life tuning under the formulator you're already qualified with, instead of bundled into one vertically integrated supplier's product roadmap.
It also protects lead time. A polyol system qualified against two or three MDI sources in parallel can absorb a plant reallocation on the isocyanate side without a re-qualification cycle on the polyol side — the formulation doesn't change just because the MDI drum's origin plant does.
The Compliance Baseline Hasn't Moved
Nothing about the merger changes diisocyanate handling rules. The EU's REACH restriction on diisocyanates (entry 74, Annex XVII) has required industrial and professional users above 0.1% concentration to complete safety training since August 2023, and that obligation sits with the end user, not the producer's shareholder structure.
In the U.S., OSHA's isocyanate exposure standards apply the same way to material from a combined OlinHuntsman as they did to legacy Huntsman product — the CAS number and safety data sheet don't change because the name on the invoice does.
Incoming QC doesn't change either: ASTM D5155 and ISO 14896 still govern isocyanate-content titration, and ASTM D4274 still governs hydroxyl-number testing on the polyol side, regardless of which entity issues the certificate of analysis.
FAQ
Q: When does the Olin-Huntsman merger officially close?
The companies are targeting the first half of 2027, after both shareholder bases approved the deal on August 25, 2026. Antitrust clearance is the remaining condition.
Q: Will MDI prices go up because of this merger?
Not automatically. The deal improves Huntsman's cost position by giving it in-house chlorine and phosgene; it doesn't reduce the number of competing MDI producers bidding for your volume.
Q: Does OlinHuntsman still operate Huntsman's existing MDI plants?
Yes. Geismar, Louisiana; Rotterdam, Netherlands; and the Caojing, China joint-venture line Huntsman split from BASF in 2023 all remain part of the combined company's production footprint.
Q: Should we switch away from Huntsman-sourced MDI before the merger closes?
Not necessarily. The more useful move is getting plant allocation and backup capacity confirmed in writing, and qualifying at least one other MDI producer in parallel.
Q: Does the merger affect diisocyanate handling or REACH training requirements?
No. REACH's diisocyanate training restriction and OSHA's isocyanate exposure standards apply to the material and the end user regardless of which company owns the producing plant.
Q: Will the merger change lead times on MDI or finished polyurethane systems?
Not directly, but ERP and order-desk consolidation during integration has historically added days to order confirmation at other large chemical mergers. Buyers who confirm plant allocation and backup capacity in writing before the close tend to avoid that delay.
